In pancreatic ductal carcinoma (PDAC), IFIT3 expression was proposed to be a prognostic marker of PDAC, as well as shown to mediate antiapoptotic activity and chemoresistance of PDAC cells [49]. This evidence concerns the gene IFIT3 and pancreatic ductal adenocarcinoma.